Memorial Sloan Kettering Cancer Center
2020 ASCO Update on Metastatic/Recurrent HNSCC: What Is the Efficacy and Tolerance of Carboplatin-Cetuximab? Is Single-Agent Chemotherapy Sufficient?
By
Nebraska Oncology Society
FEATURING
Eric Sherman
By
Nebraska Oncology Society
FEATURING
Eric Sherman
Login to view comments.
Click here to Login